Evidence map›Paper›PMID 26283726›Full record

ArticleMolecular and cellular biology2015

Whole-Body In Vivo Monitoring of Inflammatory Diseases Exploiting Human Interleukin 6-Luciferase Transgenic Mice.

Makiko Hayashi, Jun Takai, Lei Yu, Hozumi Motohashi, Takashi Moriguchi, Masayuki Yamamoto

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. The Brain Pre-Metastatic Niche: Biological and Technical Advancements.International journal of molecular sciences · 2023
    Review
  2. TheiScience · 2022
    Article
  3. Review
  4. NRF2: KEAPing Tumors Protected.Cancer discovery · 2022
    Article
  5. iScience · 2021
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Outstanding animal studies in allergy I. From asthma to food allergy and anaphylaxis.Current opinion in allergy and clinical immunology · 2017
    Review
  14. Article
  15. Review
  16. HSC Aging and Senescent Immune Remodeling.Trends in immunology · 2015
    Review
  17. Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Makiko HayashiDepartment of Medical Biochemistry, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Jun TakaiDepartment of Medical Biochemistry, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Lei YuDepartment of Medical Biochemistry, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Hozumi MotohashiDepartment of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Takashi MoriguchiDepartment of Medical Biochemistry, Graduate School of Medicine, Tohoku University, Sendai, Japan moriguch@med.tohoku.ac.jp masiyamamoto@med.tohoku.ac.jp.
Masayuki YamamotoDepartment of Medical Biochemistry, Graduate School of Medicine, Tohoku University, Sendai, Japan moriguch@med.tohoku.ac.jp masiyamamoto@med.tohoku.ac.jp.
Tohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic inflammation underlies the pathological progression of various diseases, and thus many efforts have been made to quantitatively evaluate the inflammatory status of the diseases. In this study, we generated a highly sensitive inflammation-monitoring mouse system using a bacterial artificial chromosome (BAC) clone containing extended flanking sequences of the human interleukin 6 gene (hIL6) locus, in which the luciferase (Luc) reporter gene is integrated (hIL6-BAC-Luc). We successfully monitored lipopolysaccharide-induced systemic inflammation in various tissues of the hIL6-BAC-Luc mice using an in vivo bioluminescence imaging system. When two chronic inflammatory disease models, i.e., a genetic model of atopic dermatitis and a model of experimental autoimmune encephalomyelitis (EAE), were applied to the hIL6-BAC-Luc mice, luciferase bioluminescence was specifically detected in the atopic skin lesion and central nervous system, respectively. Moreover, the Luc activities correlated well with the disease severity. Nrf2 is a master transcription factor that regulates antioxidative and detoxification enzyme genes. Upon EAE induction, the Nrf2-deficient mice crossed with the hIL6-BAC-Luc mice exhibited enhanced neurological symptoms concomitantly with robust luciferase luminescence in the neuronal tissue. Thus, whole-body in vivo monitoring using the hIL6-BAC-Luc transgenic system (WIM-6 system) provides a new and powerful diagnostic tool for real-time in vivo monitoring of inflammatory status in multiple different disease models.

Indexed as

Whole Body ImagingAnimalsAnti-Inflammatory AgentsBrainCells, CulturedDermatitis, AtopicDexamethasoneDrug Evaluation, PreclinicalEncephalomyelitis, Autoimmune, ExperimentalGenes, ReporterHumansInterleukin-6LipopolysaccharidesLuciferases, FireflyMacrophagesMice, TransgenicAnti-Inflammatory AgentsDexamethasoneIL6 protein, humanInterleukin-6LipopolysaccharidesLuciferases, FireflyNfe2l2 protein, mouseNF-E2-Related Factor 2

Identifiers

PMID26283726
PMCPMC4573709
OpenAlexW1734283958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.